|
RBBP4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.516000E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.368220E-02 |
| Normal-vs-Stage2 |
6.276200E-02 |
| Normal-vs-Stage3 |
1.038790E-03 |
| Normal-vs-Stage4 |
3.957300E-03 |
| Stage1-vs-Stage2 |
9.824400E-01 |
| Stage1-vs-Stage3 |
1.084220E-01 |
| Stage1-vs-Stage4 |
3.614200E-01 |
| Stage2-vs-Stage3 |
3.066600E-01 |
| Stage2-vs-Stage4 |
4.831600E-01 |
| Stage3-vs-Stage4 |
7.527000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.762500E-03 |
| Normal-vs-AfricanAmerican |
5.979000E-01 |
| Normal-vs-Asian |
2.624400E-02 |
| Caucasian-vs-AfricanAmerican |
1.322230E-01 |
| Caucasian-vs-Asian |
9.799600E-01 |
| AfricanAmerican-vs-Asian |
2.180400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.997900E-03 |
| Normal-vs-Female |
5.462500E-03 |
| Male-vs-Female |
6.365600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.424200E-02 |
| Normal-vs-Age(41-60Yrs) |
2.936900E-03 |
| Normal-vs-Age(61-80Yrs) |
2.896000E-03 |
| Normal-vs-Age(81-100Yrs) |
2.142800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.928800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.102600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.787800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.221800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.051200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.679400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.556380E-01 |
| Classical-VS-Follicular |
1.494100E-02 |
| Classical-VS-Other |
2.734600E-01 |
| Classical-VS-Normal |
3.785600E-02 |
| Tall-VS-Follicular |
8.572400E-01 |
| Tall-VS-Other |
7.181000E-01 |
| Tall-VS-Normal |
9.598400E-03 |
| Follicular-VS-Other |
8.294600E-01 |
| Follicular-VS-Normal |
1.723200E-03 |
| Other-VS-Normal |
7.441800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.863200E-03 |
| Normal-vs-N1 |
3.184400E-04 |
| N0-vs-N1 |
1.576560E-01 |
|
|
